CNBC's "Fast Money"

Tech stocks like Meta, Alphabet, Apple, Microsoft, and Amazon reach all-time highs. Discussion on jobs report impact and Fed's next move. Insights on second-half energy playbook, lumpy price action, and market strategies. Macy's take-private offer, Novo Nordisk shares, and potential deal with Arkhouse Management. Analysis of drug-related eye conditions, semiglutide impact, oil market predictions, EV automaker valuation, and trade strategies.

Pharma stocks decline after Biden criticizes high drug prices, while Tesla sees strong delivery numbers. Discussions on drug development costs, pricing strategies, and market trends in healthcare sector. Analyzes retail and consumer stocks performance, Tesla's upcoming RoboTaxi event, Paramount's potential sale, and impact of Citigroup downgrade on homebuilder stocks.

Apple's stock nearing record highs due to China iPhone rebound. Analysts discuss recovery in the mainland. Insights on hedging for the second half after a strong first half. Tesla's stock performance, market volatility, and investment hedging strategies. Amazon Web Services CEO interview on customer migration to the cloud and nuclear energy initiatives.

Nike's stock plummets post-earnings, creating buying opportunity. Market performance, Dell's resilience, and Citigroup's bullish stance on tech stocks. Evolution of Apple and Dell, challenges facing payment stocks, and consumer behavior impact. Trader picks review halfway through 2024, with insights on stock performance and final trade recommendations.

Nike's revenue miss and future strategies, Walgreens' stock performance, challenges in retail company with consumer trends, impact of FDA proposal on Hymns and Hers drugs, analysis of economic track records of President Biden and Former President Trump ahead of presidential debate, Fed rate cuts and market reactions on business spending and stock analysis.

Nvidia's shareholder meeting reveals growing competition in the chip industry. Bank stocks scrutinized post stress test results. Investment firm CEO optimistic about bank sector. Discusses market dominance, stock buybacks, Japan's economy, US interest rates, and consumer habits impacted by inflation.

FedEx's impressive earnings report led to a surge in shares, while the housing market faces challenges with a 'stuck' forecast. The podcast delves into the impact on related industries, home builders' resilience, and pharmaceutical giants' performance and innovations. Stock movements of Walmart and Rivian are also highlighted, along with discussions on partnerships, lounge openings, and investing in small cap stocks.

The CEO of Alnylam discusses the positive results of a new heart drug, potentially impacting the biopharma space. Market trends analyze Nvidia's stock drop and its impact on related companies. Bank opportunities, yen interventions, and challenges faced by companies are also explored.

Podcast discusses the potential slowdown of high momentum stocks like Nvidia, Sarepta's FDA approval for a muscular dystrophy drug, and market concerns over parabolic rises. Analysts upgrade Nike, while discussions include biotech stock surges, bank weaknesses, and stock market insights.

Discussion on the decline of momentum stocks like Nvidia, Chipotle, and Netflix. Gilead's positive trial results in the fight against HIV. Market speculation on potential sell-offs and corrections. Boeing and Spirit Air Systems deal analysis. Apple's stock drop and challenges with China's AI restrictions.